Neuphoria Therapeutics

NEUP

全部股東

股東類型

  • 公眾及其他55.71%
  • 機構投資者43.57%
  • 個人與內幕人士0.73%

主要股東

主要股東 最新
股東
Lynx1 Capital Management LP
16.18%87.53 萬0.00%+017/09/2026
AdvisorShares Investments, LLC
5.78%31.29 萬1.11%+6.00 萬30/09/2026
Coastlands Capital LP
4.22%22.86 萬2.01%+10.86 萬23/07/2026
Vanguard Capital Management, LLC
3.83%20.73 萬1.37%+7.52 萬30/06/2026
Shay Capital LLC
2.88%15.58 萬0.07%+4,812.0030/06/2026
Balyasny Asset Management L.P.
2.63%14.22 萬0.02%+45.0030/06/2026
Apeiron Investment Group Limited
1.34%7.26 萬<0.01%+024/01/2025
Citadel Advisors LLC
1.34%7.26 萬0.98%+5.32 萬30/06/2026
Geode Capital Management, LLC
0.92%4.95 萬0.05%-2,491.0030/06/2026
Ikarian Capital, LLC
0.88%4.74 萬<0.01%+030/06/2026
ADAR1 Capital Management, LLC
0.55%3.00 萬<0.01%+030/06/2026
FNY Investment Advisers, LLC
0.49%2.65 萬<0.01%+030/06/2026
Renaissance Technologies LLC
0.47%2.55 萬--+2.55 萬30/06/2026
XTX Markets Limited
0.43%2.31 萬0.43%+2.31 萬30/06/2026
Hudson River Trading LLC
0.42%2.29 萬--+2.29 萬30/06/2026
Jane Street Group, LLC
0.28%1.49 萬0.28%+1.49 萬30/06/2026
Boothbay Fund Management, LLC
0.26%1.40 萬<0.01%+030/06/2026
Alan FisherIndependent Non-Executive Chair of the Board
0.25%1.36 萬0.25%+1.36 萬17/09/2026
Commonwealth Equity Services, LLC
0.21%1.12 萬<0.01%+030/06/2026
Northern Trust Global Investments
0.20%1.06 萬--+1.06 萬30/06/2026